Cardiovascular Research Advance Access [Accepted Manuscript] published online on June 20, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn171
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The PGE2 – Stat3 interaction in doxorubicin-induced myocardial apoptosis
1 Division of Endocrinology, Diabetology and Nutrition, University Hospital CH-1211 Geneva, Switzerland
2 Hatter Cardiovascular Research Institute, Faculty of Health Science, University of Cape Town, South Africa
Address correspondence to: Frias Miguel A. Division of Endocrinology, Diabetology and Nutrition University Hospital 24, rue Micheli-du-Crest CH-1211 Geneva 14, Switzerland Phone: +41-22-3729322 Fax: +41-22-3729326 Email: Miguel.Frias{at}medecine.unige.ch
Aims: Both cyclooxygenase-2 (COX-2) and the transcription factor signal transducer and activator of transcription 3 (Stat3) are involved in adaptive growth and survival of cardiomyocytes. In ventricular cardiomyocytes, prostaglandin E2 (PGE2), a major COX-2 product, leads to adaptive growth via Stat3 activation, but whether this transcription factor acts as a signaling molecule in PGE2-induced cell survival is unknown. Therefore, the purpose of this study was to determine whether PGE2 counteracts cardiac apoptosis induced by doxorubicin (DOX), and if so, whether Stat3 plays a critical role in this cardioprotective effect.
Methods: Neonatal rat ventricular cardiomyocytes were incubated with DOX (0.5 µM) and/or PGE2 (1 µM). Apoptosis was assessed by determining caspase3 activation and apoptotic DNA fragmentation. The role of Stat3 was evaluated in vitro and in vivo by transfecting cardiomyocytes with siRNA targeting rat Stat3 and by using cardiomyocyte-restricted Stat3 knockout (Stat3 KO) mice, respectively.
Results: Incubation of ventricular cardiomyocytes with PGE2 led to a time-dependent decrease in the DOX –induced caspase3 activation, reaching a maximal inhibition of 70±5% after 4 h. Similarly, PGE2 inhibited DOX-induced DNA fragmentation by 58±5% after 24 h. This antiapoptotic action of PGE2 was strongly reduced by the ERK1/2 inhibitor, U0126, while the p38 MAP kinase inhibitor, SB203580, had no effect. Depleting Stat3 expression by 50-60% in isolated ventricular cardiomyocytes markedly reduced the protective effect of PGE2 on DOX-induced caspase3 activation and DNA fragmentation. Likewise, the stable PGE2 analogue, 16,16-dimethyl-PGE2, was unable to counteract cardiac apoptosis induced by DOX in Stat3 KO mice.
Conclusion: Our results demonstrate that PGE2 prevents myocardial apoptosis induced by DOX. This protection requires the activation of the prosurvival pathways of Stat3 and ERK1/2.
KEYWORDS prostaglandins; apoptosis; signal transduction
Time for primary review: 18 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. A. Frias, U. Lang, C. Gerber-Wicht, and R. W. James Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis Cardiovasc Res, September 18, 2009; (2009) cvp289v2. [Abstract] [Full Text] [PDF]
|
|